Cargando…

Outcome and Toxicity Patterns in Children and Adolescents with Non-Hodgkin Lymphoma: A Single Institution Experience

BACKGROUND: The incidence and biology of non-Hodgkin lymphoma (NHL) vary according to age. Some data suggest that the impact of age in pediatric and adolescent NHL patients depends on the histological subtype. Objectives: We aimed to analyze the impact of age at diagnosis on clinical characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelini, Paola, Rodriguez, Laura, Zolaly, Mohammed, Naqvi, Ahmed, Weitzman, Sheila, Abla, Oussama, Punnett, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841941/ https://www.ncbi.nlm.nih.gov/pubmed/29531657 http://dx.doi.org/10.4084/MJHID.2018.020

Ejemplares similares

Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma
por: Langenberg-Ververgaert, Karin P.S., et al.
Publicado: (2018)

Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study
por: Gupta, Sumit, et al.
Publicado: (2020)

Changes in EBV Association Pattern in Pediatric Classic Hodgkin Lymphoma From a Single Institution in Argentina
por: De Matteo, Elena, et al.
Publicado: (2019)

Hodgkin's Lymphoma in Children and Adolescents: A Saint Petersburg Hodgkin's Lymphoma Group Study
por: Kulyova, Svetlana A., et al.
Publicado: (2011)

A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma
por: Costantini, Danny L., et al.
Publicado: (2016)

Maintaining Efficacy But Decreasing Toxicity in the Treatment of Hodgkin Lymphoma
por: Ansell, Stephen M.
Publicado: (2017)

Bleomycin in Hodgkin's Lymphoma – A Boon or a Bane? – A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma
por: Udupa, Chethana Babu K, et al.
Publicado: (2019)

Survival and long-term toxicities of pediatric Hodgkin lymphoma after combined modality treatment: a single institute experience
por: Song, Kye Jin, et al.
Publicado: (2020)

Pulmonary toxicity induced by bleomycin in a patient with Hodgkin lymphoma
por: Oliveira, CF, et al.
Publicado: (2005)

Efficacies and Toxicities of Seven Chemotherapy Regimens for Advanced Hodgkin Lymphoma
por: Pei, Fajun, et al.
Publicado: (2021)

Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity
por: Barrett, Aisling, et al.
Publicado: (2023)

Non Hodgkin Lymphoma Among Children: Pathological Aspects and Diagnostic Challenges
por: Derqaoui, Sabrine, et al.
Publicado: (2022)

Expression and Clinical Correlation of PD-1/PD-L1 and VE1(BRAFp.V600E) in Pediatric Langerhans Cell Histiocytosis
por: Tandon, Sneha, et al.
Publicado: (2023)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020)

The Impact of Protocol Assignment for Older Adolescents with Hodgkin Lymphoma
por: Pieters, Richard S., et al.
Publicado: (2014)

Primary Pulmonary Hodgkin Lymphoma
por: Tanveer, Shumaila, et al.
Publicado: (2015)

Several immune escape patterns in non-Hodgkin's lymphomas
por: Laurent, Camille, et al.
Publicado: (2015)

Incidence patterns and review of Hodgkin lymphoma in the Republic of Armenia
por: Arakelyan, Jemma, et al.
Publicado: (2021)

Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
por: Toltz, Allison, et al.
Publicado: (2015)

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
por: Pepper, Niklas Benedikt, et al.
Publicado: (2020)

Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era
por: Follows, Annabel M., et al.
Publicado: (2022)

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience
por: Garaventa, Alberto, et al.
Publicado: (2022)

Clinicopathologic Characteristics of T-cell Non-Hodgkin's Lymphoma: A Single Institution Experience
por: Ko, Ock Bae, et al.
Publicado: (2009)

Scientific techniques in adolescent and young adult classic Hodgkin lymphoma
por: Maura, Francesco, et al.
Publicado: (2023)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Primary Vaginal Non-Hodgkin Lymphoma
por: Contreras-Chavez, Pamela, et al.
Publicado: (2018)

MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients
por: Navarro, Alfons, et al.
Publicado: (2013)

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study
por: Jona, Adam, et al.
Publicado: (2021)

Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma
por: Passalidou, E, et al.
Publicado: (2003)

Incidence Patterns and Outcomes for Hodgkin Lymphoma Patients in the United States
por: Shenoy, Pareen, et al.
Publicado: (2011)

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma
por: Castellino, Sharon M., et al.
Publicado: (2022)

Prevalence of non-Hodgkin lymphomas in São Paulo, Brazil
por: Gouveia, Gisele Rodrigues, et al.
Publicado: (2011)

Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2016)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2022)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r00tegb77s7539lpa2pet78vvc